Hyperglucagonemia and abnormal insulin-to-glucagon ratios observed in subjects with T2D contribute to pathologic hyperglycemia in both postabsorptive and fasting states by increasing hepatic glucose production [6], [16]. The gene discussed is INS; the disease is Hyperglycemia.